Revvity Inc.

Revvity Inc.

RVTY

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.79B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revvity Inc.Revvity Inc.54.60.24%3%4.50.5
$116.40

Target Price by Analysts

0.9% downsideRevvity Target Price DetailsTarget Price
$75.56

Current Fair Value

35.7% downside

Overvalued by 35.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.79 Billion
Enterprise Value$15.11 Billion
Dividend Yield$0.28 (0.24%)
Earnings per Share$2.08
Beta1.09
Outstanding Shares111,746,000

Return

Return on Equity3.29%ROE
Return on Assets1.97%
Return on Invested Capital3.31%

Valuation & Multiples

P/E Ratio54.6P/E Ratio
PEG-1384.19PEG
Price to Sales4.52Price to Sales
Price to Book Ratio1.84Price to Book Ratio
Enterprise Value to Revenue5.19
Enterprise Value to EBIT42.45
Enterprise Value to Net Income63
Total Debt to Enterprise0.22
Debt to Equity0.46Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$1.21
Average shareholder expectation
Revenue Estimate
$702.96 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 26, 2026
EPS Estimate
$1.29
Average shareholder expectation
Revenue Estimate
$694.07 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5000 1149.38%
Total Calls1,800 97.18%
Total Puts900 99.88%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %20.76% 82.46%
Total Invested$2.58B 74.48%
Investors Holding280 230.00%

ESG Score

No data

About Revvity Inc.

16,700 employees
CEO: Prahlad Singh

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...